Lucy Scientific Discovery Inc. LSDIF
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | 7.00K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 7.00K | -- | -- | -- |
| Cost of Revenue | -- | 4.50K | -- | -- | -- |
| Gross Profit | -- | 2.50K | -- | -- | -- |
| SG&A Expenses | 1.51M | 2.10M | 2.39M | 448.50K | 828.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.51M | 2.11M | 2.39M | 448.50K | 828.60K |
| Operating Income | -1.51M | -2.10M | -2.39M | -448.50K | -828.60K |
| Income Before Tax | -2.00M | -2.58M | -4.11M | -933.80K | -1.37M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.00M | -2.58M | -4.11M | -933.80K | -1.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.00M | -2.58M | -4.11M | -933.80K | -1.37M |
| EBIT | -1.51M | -2.10M | -2.39M | -448.50K | -828.60K |
| EBITDA | -1.49M | -- | -- | -- | -- |
| EPS Basic | -1.14 | -1.58 | -3.01 | -0.89 | -1.31 |
| Normalized Basic EPS | -0.68 | -0.96 | -1.34 | -0.56 | -0.82 |
| EPS Diluted | -1.14 | -1.58 | -3.01 | -0.89 | -1.31 |
| Normalized Diluted EPS | -0.68 | -0.96 | -1.34 | -0.56 | -0.82 |
| Average Basic Shares Outstanding | 1.76M | 1.63M | 1.36M | 1.04M | 1.04M |
| Average Diluted Shares Outstanding | 1.76M | 1.63M | 1.36M | 1.04M | 1.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |